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Abstract
Background and aims The aim of this study was to
investigate sexual function and the presence of lower
urinary tract symptoms (LUTS) in male patients with rectal
cancer following short-term radiotherapy and laparoscopic
total mesorectal excision (LTME) by physical and psycho-
logical measurements.
Materials and methods Sexual function and LUTS were
assessed by the use of questionnaires [International Index
of Erectile Function (IIEF), International Prostate Symptom
Score]. Sexual function was further assessed by the use of
pharmaco duplex ultrasonography of the cavernous arterial
blood flow and nocturnal penile tumescence and rigidity
monitoring (NPTR). All investigations were performed
prior to the start of preoperative radiotherapy and 15 months
after surgery.
Results Nine patients (mean age 60 years) participated.
Erectile function was maintained in 71% and ejaculation
function in 89%. Compared with pre-operative scores on
the IIEF, a significant deterioration in intercourse satisfac-
tion was seen following radiotherapy and LTME (7.9 vs
10.3, p=0.042), but overall satisfaction remained un-
changed (8.0 vs 7.0, p=0.246). NPTR parameters (duration
of erectile episodes, duration of tip rigidity ≥60%)
decreased following radiotherapy and LTME. Patients
reported a deterioration in micturition frequency (2.0 vs
1.0, p=0.034) and quality of life due to urinary symptoms
(8.0 vs 1.8, p=0.018).
Conclusion Based on these first preliminary findings, data
suggest that 15 months after short-term radiotherapy and
LTME in men with rectal cancer, objectively assessed
sexual dysfunction was considerable, but overall sexual
satisfaction had not changed.
Keywords Sexual function . Lower urinary tract symptoms .
Laparoscopy . Colorectal cancer . Total mesorectal excision
Introduction
Erectile dysfunction (ED), ejaculatory dysfunction (EJD)
and lower urinary tract symptoms (LUTS) are well-known
problems after total mesorectal excision for rectal cancer.
These problems are related to damage to pelvic autonomic
nerves caused by pre-operative radiotherapy and iatrogenic
surgical injury [1, 2].
Laparoscopic total mesorectal excision (LTME) offers
short-term advantages such as earlier diet re-establishment,
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less postoperative pain, less narcotic use and shorter
hospital stay [3–5]. Furthermore, the magnification effect
of laparoscopy enhances the exposure of the pelvic cavity.
This magnification facilitates sharp dissection of the lateral,
anterior and presacral spaces, all being autonomic nerve
locations. However, the technical demands of LTME may
just predispose to nerve injury [6].
Until now, very little is known concerning sexual
functioning and lower urinary tract symptoms after LTME
on the long term [6, 7]. A retrospective, questionnaire-
based study showed an ED incidence of 47% and an EJD
incidence of 40% [7]. Another questionnaire-based study
showed a non-significant trend towards more sexual
dysfunction after LTME [6]. These two studies showed no
differences with regard to LUTS after LTME or open TME
(OTME).
In this study, we assessed sexual functioning by an
international validated questionnaire, the International
Index of Erectile Function (IIEF), repeated pharmaco
duplex-ultrasonographic investigations of the cavernous
arteries and nocturnal penile tumescence and rigidity
(NPTR) monitoring. Lower urinary tract symptoms were
assessed by the International Prostate Symptom Score
(IPSS).
Materials and methods
The study was performed between July 2003 and January
2006. All patients underwent an elective LTME at Medical
Centre Leeuwarden [8]. The patients were included if they
were heterosexually active and if the LTME had a curative
intention. Patients with advanced T3 (cT3b) or T4
carcinoma diagnosed on magnetic resonance imaging
(MRI) were excluded. A tumour-free circumferential
resection margin of at least 2.0 mm is defined as a R0-
resection [9] and can be predicted with a high degree of
certainty when the distance on MRI is at least 6.0 mm [10].
An advanced T3 tumour was defined when the MRI
distance was less than 6.0 mm. According to the national
Dutch protocol, all patients received a short preoperative
course of 5×5 Gy radiotherapy.
The above-mentioned investigations (questionnaires,
duplex ultrasonography of the cavernous arterial blood
flow at rest and after intracavernous injection of vasoactive
substances, and nocturnal erections monitoring) were done
just before the start of the preoperative radiotherapy and at
15 months follow-up. At that time, the late side effects of
radiotherapy and the natural restoration of both psycholog-
ical and surgical factors reach their plateau phase.
The study was approved by the Committee on Medical
Research Ethics, and all patients provided written informed
consent.
Questionnaires
The patients completed two questionnaires: the Internation-
al Index of Erectile Function [11] and the International
Prostate Symptom Score [12].
The IIEF was used to assess psychological male sexual
function in short. In this questionnaire, 15 items are
checked, including erectile frequency, erection firmness,
penetration ability, maintenance frequency, maintenance
ability, intercourse frequency, intercourse satisfaction, in-
tercourse enjoyment, ejaculation frequency, orgasm fre-
quency, desire frequency, desire level, overall satisfaction,
relationship satisfaction and erection evidence. The IIEF
can only be used for heterosexual men.
The scoring systems are from 0 to 5 (0, none; 1, almost;
2, a few; 3, sometimes; 4, most times; 5, almost always) on
the first ten items and from 1 to 5 (1, very low; 2, low/a
few; 3, moderate; 4, most/high; 5, very high/almost always)
on the last five items.
The IIEF is subdivided into five response domains
(erectile function, orgasmic function, intercourse satisfac-
tion, sexual desire, overall satisfaction). The domain scores
are computed by adding the scores of individual items in
each domain.
Complete ED is defined as an erectile function domain
score <10 and partial ED as a score <17 but ≥10.
The international validated IPSS was used to assess
bladder function. The IPSS is subdivided into seven items
which include incomplete bladder emptying, frequency,
intermittency, urgency, weak stream, straining and nocturia.
The scoring system is based on a 0 to 5 scale, as follows: 0,
not at all; 1, less than one time in five; 2, less than half the
time; 3, about half the time; 4, more than half the time; and
5, almost always. The total score is calculated by adding the
item scores. Quality of life is also classified on the IPSS
and ranges from delighted to terrible (0, delighted; 1,
pleased; 2, mostly satisfied; 3, mixed about equally
satisfied and dissatisfied; 4, mostly dissatisfied; 5, unhappy;
6, terrible).
Duplex ultrasonography of the cavernous arteries
Peak flow velocities within the cavernous arteries were
measured by duplex ultrasonography before and at 1, 5, 10
and 15 min after injection of 0.25 ml Androskat® (3.75 mg
papaverinehydrocloride plus 0.125 mg phentolamine; Byk,
Zwanenburg, The Netherlands). All investigations were
performed by the same examiner using a 5-MHz pulsed
Doppler linear array transducer with B-mode colour images
and pulsed-wave Doppler. The Doppler angle-correction
cursor was adjusted to match the correct axis of flow. The
average systolic peak flow of left and right cavernosal
artery was used for further analysis.
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Nocturnal penile tumescence and rigidity measurements
To assess physical, erectile function, nocturnal penile
tumescence and rigidity were measured at home during
two consecutive nights using the RigiScan (RigiScan®,
Dacomed, Minneapolis, USA). Evaluation of nocturnal
erectile activity is typically performed while differentiating
between physical and psychogenic causes of erectile
dysfunction. NPTR testing takes advantage of the fact that
men with normal erectile function have four to six episodes
of involuntary nocturnal erections lasting 20–50 min during
6–8 h sleep cycle. These erections occur mostly during
rapid eye movement (REM) sleep. The sensitivity of the
RigiScan is 90.6%, and the specificity is 88.1% [13].
The RigiScan recorded changes in penile tumescence
and radial rigidity during the whole duration of each night.
Unfortunately, we were not able to add axial rigidometric
measurements. At the end of the, study data were analysed
with the new RigiScan Plus® software (version 4.0,
Urohealth, USA). Analysis of the recordings was focused
on the following parameters: (1) number of erectile
episodes, (2) duration of erectile episodes, (3) duration of
erectile episode with ≥60% tip rigidity [14].
Statistics
The IIEF and IPSS questionnaires were scored according to
the guidelines. Scale scores are presented as means with
standard deviations. Differences in systolic blood flow
velocities were analyzed with the Wilcoxon signed rank test,
comparing postoperative score to pre-operative score. The
comparison of questionnaires and NPTR before and after
LTME was also assessed by the Wilcoxon signed rank test.
Erectile dysfunction scored on IIEF was compared with
parameters of NPTR testing using Mann–Whitney U test.
Differences were considered to be statistically significant
when p<0.05.
Results
Nine patients were included. Table 1 shows the character-
istics of the patients, their treatments and histopathological
tumour staging.
After treatment, eight out of the nine patients (88%)
regained their sexual activities. According to the IIEF,
two of the nine patients (22%) already demonstrated
complete ED in the pre-treatment phase (defined as
domain score <10); none demonstrated partial ED (a
score <17 and ≥10) in this phase. According to the IIEF
scores, erectile function was maintained in five out of the
seven (71%) patients at 15 months follow-up, so there were
two “new” patients with ED. However, the differences
between preoperative and postoperative scores were not
significant (Table 2).
All but one of nine patients were able to ejaculate, but
that problem already existed preoperatively. Intercourse
satisfaction significantly had decreased from 10.3 preoper-
atively to 7.9 postoperatively (p=0.042).
Total mean IPSS score was 7.7±5.9 preoperatively vs
10.9±5.1 postoperatively (p>0.05; Table 3). Quality of life
due to urinary symptoms significantly decreased after
LTME (p=0.018). With regard to specific symptoms, only
frequency significantly worsened (p=0.034). All other IPSS
scores (incomplete bladder emptying, intermittency, urgen-
cy, weak stream, straining and nocturia) did not show
significant changes at 15 months follow-up (Table 3).
No statistically significant differences were observed
comparing the individual systolic peak flow velocities pre-
and postoperatively.
With regard to the NPTR parameters at 15 months
follow-up, the duration of erectile episodes (56 vs 87, p=
0.008, Fig. 1) and duration of tip rigidity ≥60% (14 vs
31, p=0.021) were decreased (Fig. 2). Figure 3 shows an
example of NPTR measures before and after treatment.
Comparison of the IIEF erectile domain scores with
NPTR parameters shows no significant differences (p>
0.05).
Table 1 Patients, treatment and tumour characteristics (N=9)
Parameter Values
Age [mean (range)] 60 (50–78)
Type of resection










Table 2 Changes in IIEF domain score pre- and postoperative
Preoperative Postoperative p
Mean SD Mean SD
Erectile function 21.0 10.7 15.2 11.8 0.104
Orgasmic function 7.2 3.9 6.4 4.6 0.465
Intercourse satisfaction 10.3 4.6 7.9 5.7 0.042
Sexual desire 6.8 2.1 6.6 2.5 0.932
Overall satisfaction 8.0 1.3 7.0 2.4 0.246
Total score 53.3 20.8 43.1 25.7 0.407
SD Standard deviation, IIEF International Index of Erectile Function
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Discussion
Radiotherapy and TME can compromise both the vascular
and the nervous system in the lower pelvis. To our
knowledge, this is the first study assessing both somatic
and psychological factors determining sexual functioning of
male patients after TME. In our view, duplex ultrasonogra-
phy of the cavernous arteries, NPTR and validated ques-
tionnaires offer the opportunity for a better understanding of
specific causes of sexual dysfunction in these patients.
Fifteen months after treatment, intercourse satisfaction,
frequency of micturition and quality of life due to urinary
symptoms had deteriorated. Although nearly all patients
(eight out of nine) had resumed sexual activities, we
observed significant decrease of NPTR parameters. These
findings suggest a partial parasympathetic nerve injury,
Table 3 Changes in IPSS before and after laparoscopic total mesorectal excision
Preoperative Postoperative p
Mean SD Mean SD
Incomplete emptying 0.6 0.9 0.7 0.7 0.739
Frequency 1.0 1.3 2.0 1.5 0.034
Intermittency 1.1 1.3 1.7 1.7 0.262
Urgency 0.4 0.7 0.6 1.0 0.914
Weak stream 1.3 1.7 1.6 1.2 0.726
Straining 1.6 2.0 0.9 1.6 0.336
Nocturia 1.7 1.0 2.0 1.4 0.618
Total IPSS 7.7 5.9 10.9 5.1 0.312
Quality of life due to urinary symptoms 1.8 1.0 8.0 5.1 0.018
SD Standard deviation, IPSS International Prostate Symptom Score
Fig. 1 Duration of erectile episodes (minutes) observed preoperative-
ly and postoperatively. x-axis represents the individual patients; y-axis
represents the duration of erectile episode in minutes
Fig. 2 Duration of tip rigidity ≥60% preoperatively and postopera-
tively. x-axis represents the individual patients; y-axis represents the
duration of tip rigidity ≥60%
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corresponding with similar results reported in patients with
rectal cancer or inflammatory bowel disease undergoing
rectal surgery [15].
The pelvic parasympathetic nerves may be damaged at a
number of points during rectal surgery. Excessive traction
on the rectum during posterior mobilization can result in
neuropraxia or even avulsion of sacral roots 2, 3 and 4. The
pelvic plexus itself is most at risk during lateral dissection
at the level of the middle haemorrhoidal vessels, to which it
is intimately related. In abdominoperineal resection, neural
injury may also occur during the perineal phase. It is
contentious to imply that the nerves are visible after
division of the rectourethralis muscle, although they are
undoubtedly vulnerable in that area.
According to prospective studies, ED and EJD rates after
TME, respectively, vary from 4% to 28% and 5% to 8%
[16–19], so the results with respect to postoperative sexual
functioning vary widely between surgeons and institutions.
According to the IIEF scores, erectile function was
maintained in five out of our seven patients (71% of the
patients), whereas EJD was reported by only one (11%).
Although sexually active, two out of the nine patients
already had ED before treatment; adequate vaginal intro-
mission was almost never possible.
Fig. 3 RigiScan traces of nocturnal erections. a Nocturnal erections
before laparoscopic total mesorectal excision; b nocturnal erections
after LTME. TIP One loop is placed around the tip of the penis; BASE
the other loop is placed around the base of the penis. x-axis represents
time (start=0 min, end=10 h); y-axis: Rig rigidity of penis is
expressed as percentages ranging from 0% to 100%; Tum tumescence
is expressed in centimetres, ranging from 5 cm to −15 cm
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Our findings suggest that after LTME, parasympathetic
nerves are more at risk than sympathetic. Quah and co-
workers, reporting on 15 men after LTME and 22 men after
OTME, found similar results concerning ED (33%) but
described just a very high EJD rate after LTME (40%) [7].
The EJD in their OTME patients was only 5%.
Based on IPSS scores, our patients had high micturition
frequencies and worse quality of life 15 months after
treatment. Especially in the pre-treatment phase, it was, for
logistic and emotional reasons, obviously not possible to
combine extended urodynamic investigations with duplex
ultrasonography and NPTR. In general, bladder dysfunction
is difficult to assess in elderly men, who may have
associated prostatic pathology, but extended urodynamic
investigations may prove neurogenic bladder disease. In
contrast with previous studies reporting on LTME, our
results suggest that also with LTME the hypogastric plexus
is still at risk resulting in neurogenic bladder dysfunction
[6, 7]. The most recent studies reporting on OTME show at
hospital discharge bladder dysfunction rates of 3.8% to
10.7% [20, 21]. Another study reporting about 6 months
after OTME shows a percentage of 10 [19].
Currently, pharmaco duplex ultrasonography is generally
accepted as the most sensitive method for evaluation of the
functional status of the penile vascular system. Using this
method, we found no relevant differences in cavernous
arterial blood flow velocities before and after LTME. These
results suggest no major vascular damage, due either to
short-term preoperative radiotherapy or to LTME.
In most cases, ED following TME is neurogenic in
origin. However, ligation of the anterior division or distal
branches of the internal iliac artery is sometimes necessary.
As all patients in our study received short-term radiother-
apy, we could not distinguish which of the two treatments,
radiotherapy or LTME, was the major causative factor for
sexual or bladder dysfunction 15 months postoperatively.
Concerning the late side effects of preoperative short-
term radiotherapy in TME patients, there are only few
studies available. Recently, data from the Dutch Colorectal
Cancer Group analysed 990 patients (497 in the radiation +
TME group and 493 in the TME only group) in terms of
health-related quality of life and sexual function. The TME
group only reported more male sexual dysfunction than the
irradiated patients, but this did not lead to significant worse
overall quality of life [1].
There are some limitations to our study. As this is a
limited study of nine non-consecutive patients, the results
are possibly subject to selection bias and therefore must be
evaluated with caution. In future, these preliminary findings
should be checked in larger series with an open control
group in a randomized controlled trial.
Despite these shortcomings, our data suggest that, in
spite of better visualization of the autonomic nerves, the
occurrence of neurogenic sexual dysfunction and LUTS
after LTME are comparable to the results found in studies
after OTME [1, 2].
Despite objectively assessed physical sexual deteriora-
tion, our patients had unchanged overall sexual satisfaction.
This corresponds with findings in patients treated for
testicular cancer [22] and with data of women treated for
gynaecological cancer [23]. This suggests that physiologi-
cal factors play probably a more determining role than
physical variables in sexual functioning in male patients
after LTME.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Marijnen CA, van de Velde CJ, Putter H, van den BM et al (2005)
Impact of short-term preoperative radiotherapy on health-related
quality of life and sexual functioning in primary rectal cancer: report
of a multicenter randomized trial. J Clin Oncol 23:1847–1858
2. Bonnel C, Parc YR, Pocard M et al (2002) Effects of
preoperative radiotherapy for primary resectable rectal adeno-
carcinoma on male sexual and urinary function. Dis Colon
Rectum 45:934–939
3. Lacy AM, Garcia-Valdecasas JC, Pique JM et al (1995) Short-term
outcome analysis of a randomized study comparing laparoscopic
vs open colectomy for colon cancer. Surg Endosc 9:1101–1105
4. Weeks JC, Nelson H, Gelber S, Sargent D, Schroeder G (2002)
Short-term quality-of-life outcomes following laparoscopic-assis-
ted colectomy vs open colectomy for colon cancer: a randomized
trial. JAMA 287:321–328
5. Breukink SO, Pierie JP, Grond AJ, Hoff C, Wiggers T, Meijerink
WJ (2005) Laparoscopic versus open total mesorectal excision: a
case-control study. Int J Colorectal Dis 20:428–433
6. Jayne DG, Brown JM, Thorpe H, Walker J, Quirke P, Guillou PJ
(2005) Bladder and sexual function following resection for rectal
cancer in a randomized clinical trial of laparoscopic versus open
technique. Br J Surg 92:1124–1132
7. Quah HM, Jayne DG, Eu KW, Seow-Choen F (2002) Bladder and
sexual dysfunction following laparoscopically assisted and conven-
tional open mesorectal resection for cancer. Br J Surg 89:1551–1556
8. Breukink SO, Pierie JP, Hoff C, Wiggers T, Meijerink WJ (2006)
Technique for laparoscopic autonomic nerve preserving total
mesorectal excision. Int J Colorectal Dis 21:308–313
9. Breukink SO, Grond AJ, Pierie JP, Hoff C, Wiggers T, Meijerink
WJ (2005) Laparoscopic versus open total mesorectal excision for
rectal cancer: An evaluation of the mesorectum’s macroscopic
quality. Surg Endosc 19:307–310
10. Beets-Tan RG, Beets GL, Vliegen RF et al (2001) Accuracy of
magnetic resonance imaging in prediction of tumour-free resection
margin in rectal cancer surgery. Lancet 357:497–504
11. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra
A (1997) The international index of erectile function (IIEF): a
multidimensional scale for assessment of erectile dysfunction.
Urology 49:822–830
12. Barry MJ, Fowler FJ Jr, O’Leary MP et al (1992) The American
Urological Association symptom index for benign prostatic
1204 Int J Colorectal Dis (2008) 23:1199–1205
hyperplasia. The Measurement Committee of the American
Urological Association. J Urol 148:1549–1557
13. Shabsigh R, Kimoto Y, Amar E et al (2004) Economical aspects
of sexual dysfunctions. In: Sexual Medicine. Eds. T.F Lue, R.
Basson, R. Rosen, F. Giuliano, S. Khoury, F. Montorsi. 2nd
International Consultation on Sexual Dysfunctions, Paris, 2004.
ISBN 0-9546956-0-7, p149.
14. Hatzichristou DG, Hatzimouratidis K, Ioannides E, Yannakoorgos
K, Dimitriadis G, Kalinderis A (1998) Nocturnal penile tumes-
cence and rigidity monitoring in young potent volunteers:
reproducibility, evaluation criteria and the effect of sexual
intercourse. J Urol 159:1921–1926
15. Lindsey I, Cunningham C, George BD, Mortensen NJ (2003)
Nocturnal penile tumescence is diminished but not ablated in
postproctectomy impotence. Dis Colon Rectum 46:14–19
16. Nesbakken A, Nygaard K, Bull-Njaa T, Carlsen E, Eri LM (2000)
Bladder and sexual dysfunction after mesorectal excision for
rectal cancer. Br J Surg 87:206–210
17. Kim NK, Aahn TW, Park JK et al (2002) Assessment of sexual
and voiding function after total mesorectal excision with pelvic
autonomic nerve preservation in males with rectal cancer. Dis
Colon Rectum 45:1178–1185
18. Pocard M, Zinzindohoue F, Haab F, Caplin S, Parc R, Tiret E
(2002) A prospective study of sexual and urinary function before
and after total mesorectal excision with autonomic nerve
preservation for rectal cancer. Surgery 131:368–372
19. Sterk P, Shekarriz B, Gunter S et al (2005) Voiding and sexual
dysfunction after deep rectal resection and total mesorectal
excision: prospective study on 52 patients. Int J Colorectal Dis
20:423–427
20. Junginger T, Kneist W, Heintz A (2003) Influence of identification
and preservation of pelvic autonomic nerves in rectal cancer
surgery on bladder dysfunction after total mesorectal excision. Dis
Colon Rectum 46:621–628
21. Kneist W, Heintz A, Junginger T (2005) Major urinary dysfunc-
tion after mesorectal excision for rectal carcinoma. Br J Surg
92:230–234
22. Jonker-Pool G, Van de Wiel HB, Hoekstra HJ et al (2001) Sexual
functioning after treatment for testicular cancer—review and
meta-analysis of 36 empirical studies between 1975–2000. Arch
Sex Behav 30:55–74
23. Weijmar Schultz WCM, van de Wiel HBM, van de Haan DEE,
van Driel MF (1993) Sexuality and cancer in women. Ann Rev
Sex Res 3:151–200
Int J Colorectal Dis (2008) 23:1199–1205 1205
